查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球疼痛治療市場：增長、未來展望、競爭分析 (2022-2030)
市場調查報告書
商品編碼
1180733

全球疼痛治療市場：增長、未來展望、競爭分析 (2022-2030)

Pain Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 118 Pages | 商品交期: 最快1-2個工作天內

價格

全球止痛藥市場的規模受到慢性疼痛疾病發病率上升、理想管道分子的大量存在、手術數量增加、肌肉骨骼和炎症性疾病的推動。預計在預測期內將顯著增長，因為外傷和內臟損傷的增加。

本報告研究和分析了全球止痛藥市場，並提供了系統信息，包括市場趨勢、競爭分析、市場動態、按細分市場和地區劃分的市場分析以及公司概況。

內容

第一章前言

第 2 章執行摘要

第 3 章止痛藥市場：競爭分析

  • 領先的疼痛治療市場供應商的市場定位
  • 疼痛治療市場供應商採用的策略
  • 主要行業戰略
  • 分層分析：2021 年與 2030 年

第 4 章疼痛治療市場：宏觀分析和市場動態

  • 簡介
  • 全球疼痛治療藥物的市場價值（2020 年至 2030 年）
  • 市場動態
    • 市場驅動因素
    • 市場製約因素
    • 主要問題
    • 重要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章疼痛治療市場：按藥物分類（2020-2030 年）

  • 市場概覽
  • 增長和收益分析：2021 年與 2030 年
  • 市場細分
    • 對乙□氨基酚/非甾體抗炎藥 (NSAID)
    • 阿片類藥物
    • 麻醉劑
    • 抗驚厥藥
    • 皮質類固醇
    • 抗抑鬱藥
    • 其他

第 6 章疼痛治療市場：按疼痛分類（2020-2030 年）

  • 市場概覽
  • 增長和收益分析：2021 年與 2030 年
  • 市場細分
    • 傷害性疼痛
    • 神經性疼痛
    • 心因性疼痛

第 7 章北美疼痛治療市場（2020-2030 年）

  • 市場概覽
  • 按藥物分類（2020-2030 年）
  • 痛苦 (2020-2030)
  • 按地區（2020-2030 年）
    • 北美

第 8 章：英國/歐盟止痛藥市場 (2020-2030)

  • 市場概覽
  • 按藥物分類（2020-2030 年）
  • 痛苦 (2020-2030)
  • 按地區（2020-2030 年）
    • 英國/歐盟

第 9 章亞太止痛藥市場（2020-2030 年）

  • 市場概覽
  • 按藥物分類（2020-2030 年）
  • 痛苦 (2020-2030)
  • 按地區（2020-2030 年）
    • 亞太地區

第 10 章拉丁美洲止痛藥市場 (2020-2030)

  • 市場概覽
  • 按藥物分類（2020-2030 年）
  • 痛苦 (2020-2030)
  • 按地區（2020-2030 年）
    • 拉丁美洲

第 11 章中東和非洲疼痛治療市場（2020-2030 年）

  • 市場概覽
  • 按藥物分類（2020-2030 年）
  • 痛苦 (2020-2030)
  • 按地區（2020-2030 年）
    • 中東和非洲

第12章公司簡介

  • Abbott Laboratories
  • AstraZeneca plc.
  • Biogen Idec Inc.
  • Bristol-Myers Squibb and Company
  • Depomed Inc.
  • Eli Lily and Company
  • GlaxoSmithKline PLC.
  • Johnson & Johnson Services Inc.
  • Mallinckrodt plc.
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Purdue Pharma L.P.
  • Sanofi S.A.
  • 他
Product Code: 137861-08-22

Pain therapeutics are used to relieve pain either by stopping the pain signals or by altering the brain interpretation to these signals. Pain therapeutics have the ability to reduce pain intensity but do not treat the cause of the pain. The global pain therapeutics market is anticipated to grow significantly over the forecast period due to growing incidence of chronic and pain inducing illnesses, strong presence of ideal pipeline molecules, growing number of surgeries and rising number of musculoskeletal disease, inflammatory disease, trauma and injuries to the internal organ.

The report titled "Pain Therapeutics Market - Growth, Future Prospects and Competitive Analysis, 2022-2030" offers in-depth understanding into the overall pain therapeutics market size for duration 2022 to 2030. The report study covers detail analysis of pain therapeutics market segment based on drug class (acetaminophen and nonsteroidal anti-inflammatory drugs, opioids, anesthetics, anticonvulsants, corticosteroids, antidepressants, other) and pain type (nociceptive pain, neuropathic pain and psychogenic pain).

This study covered in-depth the study of geographical market segment. Market size and forecast is studied for regional and country level markets such as Europe (Germany, United Kingdom, and Rest of Europe), North America (Canada and United States), Latin America (Mexico, Brazil and Rest of Latin America), Asia Pacific (China, japan and Rest of APAC), Middle East and Africa (GCC and Rest of Middle East and Africa).

Along with the statistical information, qualitative information is also included in report for further understanding of current market position and future market scenario. To provide information related to ongoing trend of market, in-depth information related to pain therapeutics market drivers, opportunities and challenges are also included in this report. In addition, competitive environment, information related to the market positioning of key manufacturer and attractive investment proposition are also covered in this report.

Pain therapeutics are used to relieve pain either by stopping the pain signals or by altering the brain interpretation to these signals. Growing number of chronic diseases, increasing number of surgeries and strong presence of pipeline drugs are the prime factors driving the growth of pain therapeutics market globally. It is observed that pain therapeutics market is saturated by a multitude of manufacturers and thus major players in pain therapeutics market are trying to distinguish their products to avoid price competition. It is studied that the demand for NSAIDs and opiods is the highest in market due to their effectives in treatment of pain. Easy availability and increase in use of low cost NSAIDs and acetaminophen in treatment of different conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, arthritis, gout, minor injuries, joint pain etc. are assisting the growth of NSAIDs market globally. According to the Centers for Disease Control and Prevention (CDC), in 2014, approximately 2 million Americans, aged 12 or more are either dependent on prescription opioids or drug abuse. Stringent regulatory guidelines for use of opiods such as oxycodone, hydrocodone, meperidine, hydromorphone and propoxyphene etc. may negatively impact the growth of opioids drugs market, globally. Due to increasing death toll from opioid overdose, the Drug Enforcement Administration (DEA) announced that, opioid medications manufactured for sales and research in the United States in 2017 will be reduced by 25%.

According to the National Center for Health Statistics, one in every four Americans is suffering from pain. It is observed that currently the demand for nociceptive pain therapeutics is the highest in market as it is the most common among the all types of pain. Rising number of patients suffering with arthritis, myofascial pain, fibromyalgia, bone pain, fractures, joint pain, inflammation and trauma related to interior organ etc. are driving the growth of pain therapeutics market for nociceptive pain. The demand for pain therapeutics used for treating neuropathic pain will show the fastest market growth over the forecast period due to the higher unmet needs, strong presence of ideal pipeline molecules and growing number of conditions such as multiple sclerosis, multiple myeloma, diabetes, cancer, neuralgia etc. Expected launch of pipeline drugs such as GRO-12, REGN-475, KRN 5500, xpf-002, TV-45070, PF-04383119, AGN-203818 would assist the growth of neuropathic pain therapeutics during forecast period 2021 to 2029.

Among the considered geographical segments, North America is current leader in global pain therapeutics market. The dominance of this region is majorly driven by United Sates due to key factors such as higher cost of pain relieving therapeutics, increase in number of affected population, growing number of pain management centers, higher demand for pain therapeutics, and easy availability of novel pain management drugs. According to the National Institutes of Health (NIH), approximately 100 million Americans, or one third of the United States population is affected with chronic pain. The key players in the North America continue to focus in research and development activities and tend to provide ideal pain management therapeutics in the near future. Expected launch of novel pain drugs such as GRO-12, REGN-475, KRN-5500, xpf-002, TV-45070, PF-04383119, AGN-203818 etc. would further assist market growth in North America. On other hand, Asia Pacific is anticipated to show significant market growth over the forecast period due increasing penetration of key players in emerging market such as China and India, increasing R&D investment, large pool of patients, growing healthcare expenditure and rising government funding and initiatives in healthcare systems.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Pain Therapeutics market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Pain Therapeutics market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Market Segmentation

Drug

Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Opioids

Anesthetics

Anticonvulsants

Corticosteroids

Antidepressants

Other

Pain

Nociceptive Pain

Somatic Pain

Visceral Pain

Cutaneous Pain

Neuropathic Pain

Psychogenic Pain

Region Segment (2020-2030; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Global Impact of Covid-19 Segment (2020-2021; US$ Million )

Pre Covid-19 situation

Post Covid-19 situation

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Pain Therapeutics market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2030.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Pain Therapeutics market?

Which is the largest regional market for Pain Therapeutics market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Pain Therapeutics market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Pain Therapeutics market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Pain Therapeutics Market
  • 2.2. Global Pain Therapeutics Market, By Drug, 2021 (US$ Million)
  • 2.3. Global Pain Therapeutics Market, By Pain, 2021 (US$ Million)
  • 2.4. Global Pain Therapeutics Market, By Geography, 2021 (US$ Million)
  • 2.5. Attractive Investment Proposition by Geography, 2021

3. Pain Therapeutics Market: Competitive Analysis

  • 3.1. Market Positioning of Key Pain Therapeutics Market Vendors
  • 3.2. Strategies Adopted by Pain Therapeutics Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2021 Versus 2030

4. Pain Therapeutics Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Pain Therapeutics Market Value, 2020 - 2030, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Acetaminophen and Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • 5.3.2. Opioids
    • 5.3.3. Anesthetics
    • 5.3.4. Anticonvulsants
    • 5.3.5. Corticosteroids
    • 5.3.6. Antidepressants
    • 5.3.7. Other

6. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 6.3. Market Segmentation
    • 6.3.1. Nociceptive Pain
      • 6.3.1.1. Somatic Pain
      • 6.3.1.2. Visceral Pain
      • 6.3.1.3. Cutaneous Pain
    • 6.3.2. Neuropathic Pain
    • 6.3.3. Psychogenic Pain

7. North America Pain Therapeutics Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
  • 7.3. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
  • 7.4.Pain Therapeutics Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.North America
      • 7.4.1.1. U.S.
        • 7.4.1.1.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 7.4.1.1.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 7.4.1.2. Canada
        • 7.4.1.2.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 7.4.1.2.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 7.4.1.3. Rest of North America
        • 7.4.1.3.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 7.4.1.3.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)

8. UK and European Union Pain Therapeutics Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
  • 8.3. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
  • 8.4.Pain Therapeutics Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.UK and European Union
      • 8.4.1.1. UK
        • 8.4.1.1.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.1.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 8.4.1.2. Germany
        • 8.4.1.2.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.2.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 8.4.1.3. Spain
        • 8.4.1.3.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.3.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 8.4.1.4. Italy
        • 8.4.1.4.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.4.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 8.4.1.5. France
        • 8.4.1.5.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.5.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 8.4.1.6. Rest of Europe
        • 8.4.1.6.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 8.4.1.6.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)

9. Asia Pacific Pain Therapeutics Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
  • 9.3. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
  • 9.4.Pain Therapeutics Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Asia Pacific
      • 9.4.1.1. China
        • 9.4.1.1.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.1.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 9.4.1.2. Japan
        • 9.4.1.2.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.2.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 9.4.1.3. India
        • 9.4.1.3.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.3.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 9.4.1.4. Australia
        • 9.4.1.4.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.4.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 9.4.1.5. South Korea
        • 9.4.1.5.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.5.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 9.4.1.6. Rest of Asia Pacific
        • 9.4.1.6.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 9.4.1.6.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)

10. Latin America Pain Therapeutics Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
  • 10.3. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
  • 10.4.Pain Therapeutics Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Latin America
      • 10.4.1.1. Brazil
        • 10.4.1.1.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 10.4.1.1.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 10.4.1.2. Mexico
        • 10.4.1.2.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 10.4.1.2.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 10.4.1.3. Rest of Latin America
        • 10.4.1.3.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 10.4.1.3.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)

11. Middle East and Africa Pain Therapeutics Market, 2020-2030, USD (Million)

  • 11.1. Market Overview
  • 11.2. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
  • 11.3. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
  • 11.4.Pain Therapeutics Market: By Region, 2020-2030, USD (Million)
    • 11.4.1.Middle East and Africa
      • 11.4.1.1. GCC
        • 11.4.1.1.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 11.4.1.1.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 11.4.1.2. Africa
        • 11.4.1.2.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 11.4.1.2.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)
      • 11.4.1.3. Rest of Middle East and Africa
        • 11.4.1.3.1. Pain Therapeutics Market: By Drug, 2020-2030, USD (Million)
        • 11.4.1.3.1. Pain Therapeutics Market: By Pain, 2020-2030, USD (Million)

12. Company Profile

  • 12.1. Abbott Laboratories
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Portfolio
    • 12.1.4. Strategic Initiatives
  • 12.2. AstraZeneca plc.
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Portfolio
    • 12.2.4. Strategic Initiatives
  • 12.3. Biogen Idec Inc.
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Portfolio
    • 12.3.4. Strategic Initiatives
  • 12.4. Bristol-Myers Squibb and Company
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Portfolio
    • 12.4.4. Strategic Initiatives
  • 12.5. Depomed Inc.
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Portfolio
    • 12.5.4. Strategic Initiatives
  • 12.6. Eli Lily and Company
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Portfolio
    • 12.6.4. Strategic Initiatives
  • 12.7. GlaxoSmithKline PLC.
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Portfolio
    • 12.7.4. Strategic Initiatives
  • 12.8. Johnson & Johnson Services Inc.
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Portfolio
    • 12.8.4. Strategic Initiatives
  • 12.9. Mallinckrodt plc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Portfolio
    • 12.9.4. Strategic Initiatives
  • 12.10. Merck & Co. Inc.
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Portfolio
    • 12.10.4. Strategic Initiatives
  • 12.11. Novartis AG
    • 12.11.1. Company Overview
    • 12.11.2. Financial Performance
    • 12.11.3. Product Portfolio
    • 12.11.4. Strategic Initiatives
  • 12.12. Pfizer Inc.
    • 12.12.1. Company Overview
    • 12.12.2. Financial Performance
    • 12.12.3. Product Portfolio
    • 12.12.4. Strategic Initiatives
  • 12.13. Purdue Pharma L.P.
    • 12.13.1. Company Overview
    • 12.13.2. Financial Performance
    • 12.13.3. Product Portfolio
    • 12.13.4. Strategic Initiatives
  • 12.14. Sanofi S.A.
    • 12.14.1. Company Overview
    • 12.14.2. Financial Performance
    • 12.14.3. Product Portfolio
    • 12.14.4. Strategic Initiatives
  • 12.15. Other Notable Players
    • 12.15.1. Company Overview
    • 12.15.2. Financial Performance
    • 12.15.3. Product Portfolio
    • 12.15.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 2 Global Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 3 Global Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 4 North America Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 5 North America Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 6 North America Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 7 U.S. Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 8 U.S. Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 9 U.S. Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 10 Canada Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 11 Canada Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 12 Canada Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 13 Rest of North America Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 14 Rest of North America Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 15 Rest of North America Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 16 UK and European Union Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 17 UK and European Union Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 18 UK and European Union Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 19 UK Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 20 UK Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 21 UK Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 22 Germany Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 23 Germany Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 24 Germany Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 25 Spain Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 26 Spain Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 27 Spain Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 28 Italy Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 29 Italy Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 30 Italy Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 31 France Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 32 France Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 33 France Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 34 Rest of Europe Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 35 Rest of Europe Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 36 Rest of Europe Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 37 Asia Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 38 Asia Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 39 Asia Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 40 China Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 41 China Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 42 China Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 43 Japan Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 44 Japan Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 45 Japan Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 46 India Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 47 India Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 48 India Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 49 Australia Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 50 Australia Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 51 Australia Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 52 South Korea Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 53 South Korea Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 54 South Korea Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 55 Latin America Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 56 Latin America Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 57 Latin America Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 58 Brazil Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 59 Brazil Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 60 Brazil Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 61 Mexico Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 62 Mexico Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 63 Mexico Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 64 Rest of Latin America Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 65 Rest of Latin America Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 66 Rest of Latin America Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 67 Middle East and Africa Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 68 Middle East and Africa Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 69 Middle East and Africa Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 70 GCC Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 71 GCC Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 72 GCC Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 73 Africa Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 74 Africa Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 75 Africa Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Pain Therapeutics Market By Drug, 2020-2030, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Pain Therapeutics Market By Pain, 2020-2030, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Pain Therapeutics Market By Nociceptive Pain, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Pain Therapeutics Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Pain Therapeutics Market: Quality Assurance
  • FIG. 5 Global Pain Therapeutics Market, By Drug, 2021
  • FIG. 6 Global Pain Therapeutics Market, By Pain, 2021
  • FIG. 7 Global Pain Therapeutics Market, By Geography, 2021
  • FIG. 8 Market Geographical Opportunity Matrix - Global Pain Therapeutics Market, 2021
  • FIG. 9 Market Positioning of Key Pain Therapeutics Market Players, 2021
  • FIG. 10 Global Pain Therapeutics Market - Tier Analysis - Percentage of Revenues by Tier Level, 2021 Versus 2030
  • FIG. 11 Global Pain Therapeutics Market, By Drug, 2021 Vs 2030, %
  • FIG. 12 Global Pain Therapeutics Market, By Pain, 2021 Vs 2030, %
  • FIG. 13 U.S. Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 14 Canada Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 15 Rest of North America Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 16 UK Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 17 Germany Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 18 Spain Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 19 Italy Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 20 France Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 21 Rest of Europe Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 22 China Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 23 Japan Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 24 India Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 25 Australia Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 26 South Korea Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Asia Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 28 Brazil Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 29 Mexico Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Latin America Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 31 GCC Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 32 Africa Pain Therapeutics Market (US$ Million), 2020 - 2030
  • FIG. 33 Rest of Middle East and Africa Pain Therapeutics Market (US$ Million), 2020 - 2030